Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring
Not Applicable
Completed
- Conditions
- Cicatrix
- Interventions
- Device: non-ablative laser
- Registration Number
- NCT02645773
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
To investigate intervention with early application of non-ablative laser to prevent scarring in the skin
- Detailed Description
To intervene in scar formation at three different time-points
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 16
Inclusion Criteria
- good health
- men
- Skin type 2-3
- non-smokers
- presenting full medical record
Exclusion Criteria
- active skin disease in test area
- resent UV-exposure in test area
- history of keloid
- current or resent cancer
- uncontrolled systemical disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pre-laser non-ablative laser non-ablative laser Laser Pre-wounding low dose laser Pre-wounding medium dose laser Pre-wounding high dose Immediate-laser non-ablative laser non-ablative laser Laser low dose - immediate after wounding Laser medium dose - immediate after wounding Laser high dose - immediate after wounding Post-laser non-ablative laser non-ablative laser Laser low dose - post wounding Laser medium dose - post wounding Laser medium dose - post wounding
- Primary Outcome Measures
Name Time Method To measure the clinical effect on scarring of non-ablative laser intervention at the three time-points 3 months after Clinical evaluation by scar scales
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does non-ablative fractional laser modulate in cicatrix prevention?
How does early non-ablative laser therapy compare to silicone gel in scar prevention efficacy?
Which biomarkers correlate with improved outcomes in NCT02645773 laser scar intervention?
What adverse events are associated with non-ablative fractional laser in early scar treatment?
Are there combination therapies with non-ablative lasers for hypertrophic scar management in clinical trials?
Trial Locations
- Locations (1)
Bispebjerg Hospital
🇩🇰Copenhagen, Denmark